Asthma Clinical Research Network (ACRN)

This study has been completed.

First Received: October 27, 1999 Last Updated: August 24, 2006 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00000577

Purpose

This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.

Condition	Intervention	Phase
Asthma Lung Diseases	Drug: Albuterol Drug: Colchicine Drug: Adrenal Cortex Hormones Drug: Adrenergic-Beta Agonists	Phase III

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Official Title:	Asthma Clinical Research Network (ACRN)

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Drug Information available for: Colchicine Albuterol Levalbuterol hydrochloride Albuterol sulfate Levalbuterol tartrate

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	September 1993
Estimated Study Completion Date:	July 2008

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Patients with asthma; specific eligibility criteria vary for each study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000577

Locations

United States, California
University of California, San Francisco
San Francisco, California, United States, 94143
University of California at San Diego
La Jolla, California, United States, 92103
United States, Colorado
National Jewish Medical & Research Center
Denver, Colorado, United States, 80206
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
United States, Missouri
Washington University
St. Louis, Missouri, United States, 63110
United States, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27103
United States, Wisconsin
University of Wisconsin at Madison
Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Study Chair:	Homer A. Boushey	University of California, San Francisco
Study Chair:	William Calhoun	University of Pittsburgh at Pittsburgh
Study Chair:	Mario Castro	Washington University School of Medicine
Study Chair:	Vernon Chinchilli	Pennsylvania State University - Hershey Medical Center
Study Chair:	Elliot Israel	Brigham and Women's Hospital
Study Chair:	Robert F. Lemanske, Jr.	University of Wisconsin at Madison
Study Chair:	Richard J. Martin	National Jewish Medical & Research Center
Study Chair:	Stephen P. Peters	Wake Forest University
Study Chair:	Stephen I. Wasserman	University of California, San Diego

Study ID Numbers:	215, U10 HL51823, U10 HL51831, U10 HL51834, U10 HL51843, U10 HL51845, U10 HL56443, U10 HL74073, U10 HL74204, U10 HL74206, U10 HL74208, U10 HL74212, U10 HL74218, U10 HL74225, U10 HL74227, U10 HL74231, Y02 HL51810
Study First Received:	October 27, 1999
Last Updated:	August 24, 2006
ClinicalTrials.gov Identifier:	NCT00000577 History of Changes
Health Authority:	United States: Federal Government